CLOV Relative Valuation
CLOV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLOV is overvalued; if below, it's undervalued.
Historical Valuation
Clover Health Investments Corp (CLOV) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -11.46. The fair price of Clover Health Investments Corp (CLOV) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.60
Fair
-33.29
PE
1Y
3Y
5Y
Trailing
Forward
38.96
EV/EBITDA
Clover Health Investments Corp. (CLOV) has a current EV/EBITDA of 38.96. The 5-year average EV/EBITDA is 7.40. The thresholds are as follows: Strongly Undervalued below -32.84, Undervalued between -32.84 and -12.72, Fairly Valued between 27.52 and -12.72, Overvalued between 27.52 and 47.64, and Strongly Overvalued above 47.64. The current Forward EV/EBITDA of 38.96 falls within the Overvalued range.
-13.52
EV/EBIT
Clover Health Investments Corp. (CLOV) has a current EV/EBIT of -13.52. The 5-year average EV/EBIT is -7.94. The thresholds are as follows: Strongly Undervalued below -24.65, Undervalued between -24.65 and -16.30, Fairly Valued between 0.41 and -16.30, Overvalued between 0.41 and 8.77, and Strongly Overvalued above 8.77. The current Forward EV/EBIT of -13.52 falls within the Historic Trend Line -Fairly Valued range.
0.55
PS
Clover Health Investments Corp. (CLOV) has a current PS of 0.55. The 5-year average PS is 0.94. The thresholds are as follows: Strongly Undervalued below -1.28, Undervalued between -1.28 and -0.17, Fairly Valued between 2.04 and -0.17, Overvalued between 2.04 and 3.15, and Strongly Overvalued above 3.15. The current Forward PS of 0.55 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Clover Health Investments Corp. (CLOV) has a current P/OCF of 0.00. The 5-year average P/OCF is -4.68. The thresholds are as follows: Strongly Undervalued below -21.99, Undervalued between -21.99 and -13.33, Fairly Valued between 3.98 and -13.33, Overvalued between 3.98 and 12.64, and Strongly Overvalued above 12.64. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Clover Health Investments Corp. (CLOV) has a current P/FCF of 0.00. The 5-year average P/FCF is -8.61. The thresholds are as follows: Strongly Undervalued below -24.52, Undervalued between -24.52 and -16.56, Fairly Valued between -0.65 and -16.56, Overvalued between -0.65 and 7.31, and Strongly Overvalued above 7.31. The current Forward P/FCF of 0.00 falls within the Overvalued range.
Clover Health Investments Corp (CLOV) has a current Price-to-Book (P/B) ratio of 3.95. Compared to its 3-year average P/B ratio of 3.01 , the current P/B ratio is approximately 31.09% higher. Relative to its 5-year average P/B ratio of 3.42, the current P/B ratio is about 15.41% higher. Clover Health Investments Corp (CLOV) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -20.74%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -17.18% , the current FCF yield is about -100.00% lower.
4.01
P/B
Median3y
3.01
Median5y
3.42
-6.38
FCF Yield
Median3y
-20.74
Median5y
-17.18
Competitors Valuation Multiple
The average P/S ratio for CLOV's competitors is , providing a benchmark for relative valuation. Clover Health Investments Corp Corp (CLOV) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 50.05%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CLOV decreased by 15.56% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.65 to -4.91.
The secondary factor is the Revenue Growth, contributed 50.05%to the performance.
Overall, the performance of CLOV in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Clover Health Investments Corp (CLOV) currently overvalued or undervalued?
What is Clover Health Investments Corp (CLOV) fair value?
How does CLOV's valuation metrics compare to the industry average?
What is the current P/B ratio for Clover Health Investments Corp (CLOV) as of Dec 05 2025?
What is the current FCF Yield for Clover Health Investments Corp (CLOV) as of Dec 05 2025?
What is the current Forward P/E ratio for Clover Health Investments Corp (CLOV) as of Dec 05 2025?